Proposals for the rheumatological use of JAK inhibitors

Nature Reviews Rheumatology, Published online: 12 January 2024; doi:10.1038/s41584-023-01068-3Janus kinase inhibitors have therapeutic potential for patients with immune-mediated inflammatory diseases, and evidence of greater risks of cardiovascular disease and malignancy than with TNF inhibitors should be carefully considered before recommendations against their use are made. Assessment of the risk–benefit ratios in these patients can instead guide clinical decision-making.
Source: Nature Reviews Rheumatology - Category: Rheumatology Authors: Source Type: research